These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23832543)

  • 1. Overexpression of ILK1 in breast cancer associates with poor prognosis.
    Yang HJ; Zheng YB; Ji T; Ding XF; Zhu C; Yu XF; Ling ZQ
    Tumour Biol; 2013 Dec; 34(6):3933-8. PubMed ID: 23832543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OLC1 is overexpressed in breast cancer and its expression correlates with poor patient survival.
    Ou-Yang QH; Duan ZX; Jin Z; Lei JX
    Tumour Biol; 2014 Sep; 35(9):8823-7. PubMed ID: 24880589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of integrin-linked kinase1 overexpression in astrocytoma.
    Li J; Zhang H; Wu J; Guan H; Yuan J; Huang Z; Li M
    Int J Cancer; 2010 Mar; 126(6):1436-44. PubMed ID: 19676046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.
    Ding ZY; Wu HR; Zhang JM; Huang GR; Ji DD
    Int J Clin Exp Pathol; 2014; 7(2):722-7. PubMed ID: 24551295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
    Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
    Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis.
    Chen Y; Wang S; He Z; Sun F; Huang Y; Ni Q; Wang H; Wang Y; Cheng C
    Hum Pathol; 2017 Aug; 66():48-58. PubMed ID: 28554575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
    Asano T; Sato S; Yoshimoto N; Endo Y; Hato Y; Dong Y; Takahashi S; Fujii Y; Toyama T
    Jpn J Clin Oncol; 2014 Oct; 44(10):889-97. PubMed ID: 25163465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression.
    Huang Z; Li X; Xie T; Gu C; Ni K; Yin Q; Cao X; Zhang C
    Cancer Res Treat; 2020 Oct; 52(4):1067-1083. PubMed ID: 32599985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
    Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
    Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
    Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
    Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
    Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
    Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.
    Ni SS; Zhang J; Zhao WL; Dong XC; Wang JL
    Tumour Biol; 2013 Jun; 34(3):1813-8. PubMed ID: 23475633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of OSR1 as a predictive biomarker for poor prognosis and lymph node metastasis in breast cancer.
    Li Y; Qin J; Wu J; Dai X; Xu J
    Breast Cancer Res Treat; 2020 Jul; 182(1):35-46. PubMed ID: 32424721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
    Guo J; Dong B; Ji JF; Wu AW
    World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.